Choice of the optimal metastatic lymph node marking in patients with breast cancer

Often, neoadjuvant treatment in patients with locally advanced breast cancer leads to complete clinical and pathomorphological regression of not only the primary tumor, but metastatic lymph nodes also. Currently, discussions are ongoing regarding optimal volume surgical intervention on regional this category patients. As a de-escalation classical lymphadenectomy, method targeted axillary dissection (TAD) is used, which presumes biopsy sentinel (SLN) removal previously marked node. Our study aimed at choosing most for labeling The included 63 diagnosed stage T1–3N1M0 cancer, all divided into two comparison groups: 29 had radiopaque label placed node before therapy, 33 radioisotope (with I125). After completion, response underwent lymphadenectomy. We evaluated time intervention, length skin incision, presence complications when using one or another type marking. Based results statistical analysis, we propose variant implementation practice. This method, our opinion, presented best qualities, reliability convenience surgeon, comfort patient.